1343P - Real life use of talimogene laherparepvec in melanoma in centers in Austria and Switzerland

C. Hoeller; J.m. Ressler; M. Karasek; V Aedo Lopez; L. Koch; H. Kehrer; P. Koelblinger; F. Weihsengruber; J. Kofler; E. Richtig; O.a. Michielin; C. Hafner

doi:10.1093/annonc/mdz255.032

1343P - Real life use of talimogene laherparepvec in melanoma in centers in Austria and Switzerland

C. Hoeller, J.m. Ressler, M. Karasek, V Aedo Lopez, L. Koch, H. Kehrer, P. Koelblinger, F. Weihsengruber, J. Kofler, E. Richtig, O.a. Michielin, C. Hafner

Division of Dermatology and Venereal Diseases (University Hospital St. Pölten)

Research output: Contribution to book/report/conference proceeding › Contribution to conference proceeding

Original language	English
Title of host publication	Abstract Book of the 44th ESMO Congress (ESMO 2019) 27 September – 1 October 2019, Barcelona, Spain
Pages	v548-v549
Volume	30
DOIs	https://doi.org/10.1093/annonc/mdz255.032
Publication status	Published - 1 Oct 2019

Publication series

Name	Annals of Oncology
Publisher	Elsevier Ltd.
ISSN (Print)	0923-7534

Access to Document

10.1093/annonc/mdz255.032Licence: Other

https://linkinghub.elsevier.com/retrieve/pii/S0923753419595539

Cite this

Hoeller, C., Ressler, J. M., Karasek, M., Lopez, V. A., Koch, L., Kehrer, H., Koelblinger, P., Weihsengruber, F., Kofler, J., Richtig, E., Michielin, O. A., & Hafner, C. (2019). 1343P - Real life use of talimogene laherparepvec in melanoma in centers in Austria and Switzerland. In Abstract Book of the 44th ESMO Congress (ESMO 2019) 27 September – 1 October 2019, Barcelona, Spain (Vol. 30, pp. v548-v549). (Annals of Oncology). https://doi.org/10.1093/annonc/mdz255.032

@inproceedings{bbf96f9e290a49c8b3b53f8305de4b39,

title = "1343P - Real life use of talimogene laherparepvec in melanoma in centers in Austria and Switzerland",

author = "C. Hoeller and J.m. Ressler and M. Karasek and Lopez, {V Aedo} and L. Koch and H. Kehrer and P. Koelblinger and F. Weihsengruber and J. Kofler and E. Richtig and O.a. Michielin and C. Hafner",

year = "2019",

month = oct,

day = "1",

doi = "10.1093/annonc/mdz255.032",

language = "English",

volume = "30",

series = "Annals of Oncology",

publisher = "Elsevier Ltd.",

pages = "v548--v549",

booktitle = "Abstract Book of the 44th ESMO Congress (ESMO 2019) 27 September – 1 October 2019, Barcelona, Spain",

}

Hoeller, C, Ressler, JM, Karasek, M, Lopez, VA, Koch, L, Kehrer, H, Koelblinger, P, Weihsengruber, F, Kofler, J, Richtig, E, Michielin, OA & Hafner, C 2019, 1343P - Real life use of talimogene laherparepvec in melanoma in centers in Austria and Switzerland. in Abstract Book of the 44th ESMO Congress (ESMO 2019) 27 September – 1 October 2019, Barcelona, Spain. vol. 30, Annals of Oncology, pp. v548-v549. https://doi.org/10.1093/annonc/mdz255.032

1343P - Real life use of talimogene laherparepvec in melanoma in centers in Austria and Switzerland. / Hoeller, C.; Ressler, J.m.; Karasek, M. et al.

Abstract Book of the 44th ESMO Congress (ESMO 2019) 27 September – 1 October 2019, Barcelona, Spain. Vol. 30 2019. p. v548-v549 (Annals of Oncology).

Research output: Contribution to book/report/conference proceeding › Contribution to conference proceeding

TY - GEN

T1 - 1343P - Real life use of talimogene laherparepvec in melanoma in centers in Austria and Switzerland

AU - Hoeller, C.

AU - Ressler, J.m.

AU - Karasek, M.

AU - Lopez, V Aedo

AU - Koch, L.

AU - Kehrer, H.

AU - Koelblinger, P.

AU - Weihsengruber, F.

AU - Kofler, J.

AU - Richtig, E.

AU - Michielin, O.a.

AU - Hafner, C.

PY - 2019/10/1

Y1 - 2019/10/1

U2 - 10.1093/annonc/mdz255.032

DO - 10.1093/annonc/mdz255.032

M3 - Contribution to conference proceeding

VL - 30

T3 - Annals of Oncology

SP - v548-v549

BT - Abstract Book of the 44th ESMO Congress (ESMO 2019) 27 September – 1 October 2019, Barcelona, Spain

ER -